麻豆传媒

Charles Bankhead

Charles Bankhead

Authors >

Charles Bankhead

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. His career spans more than 30 years, including a decade with Medical World News, a leading medical trade magazine of its time. He had a long and successful freelance career before joining 麻豆传媒 in 2007. Charles graduated with honors from Texas Tech University, receiving a BA in journalism, and completed a master's degree in mass communication, with specialization in health communication, also at Texas Tech.

Connect:

email image

Latest from Charles Bankhead

A computer rendering of a transparent body with a bladder tumor highlighted.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

Almost half of patients in active surveillance avoided cystectomy during 40 months of follow-up

A photo of a man holding a cardboard container of four to-go cups of coffee.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

Meta-analysis shows inverse dose-response relationship for both beverages

Onco Break over a computer rendering of a cancer cell.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

News, features, and commentary about cancer-related issues

A computer rendering of breast cancer.

Sticking With CDK4/6 Inhibitors for Breast Cancer Wins in Post-Progression Setting

Lack of biomarkers handicaps decision making in era of expanding treatment options

FDA APPROVED remestemcel-L (Ryoncil) over a photo of a bag of stem cells in a purple rubber-gloved hand.

FDA Approves Mesenchymal Stromal Cell Therapy for Refractory Acute GVHD in Kids

Response rate of 70% at day 28 with remestemcel-L

SABCS over a photo of the Henry B. Gonzalez Convention Center in San Antonio, TX.

Skipping Chest-Wall Irradiation After Mastectomy in Intermediate-Risk Breast Cancer

No improvement in survival or impact on recurrence, but pending studies leave door ajar

SABCS over a photo of the Henry B. Gonzalez Convention Center in San Antonio, TX.

Mixed Signals From Trials of Perioperative, Neoadjuvant Immunotherapy for Early TNBC

Adding atezolizumab, camrelizumab to chemotherapy improves pCR but not survival endpoints

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

Homing in on Anthracyclines' High-Risk Niche in Early Breast Cancer

Significant improvement in 5-year distant relapse-free interval with higher risk score

Onco Break over a computer rendering of a cancer cell.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

News, features, and commentary about cancer-related issues

SABCS over a photo of Henry B. Gonzalez Convention Center in San Antonio, TX.

No Apparent Harm From Omitting Lymph Node Dissection in Selected Breast Cancers

Nearly identical 5-year outcomes with no surgery, sentinel lymph node biopsy

1

鈥�